Table 2.
Overview of histologic outcomes (N, %).
| Histology | N (%) |
|---|---|
| Endometrioma | 344 (20.8%) |
| Teratoma | 231 (14.0%) |
| Simple cyst + parasalpingeal cyst | 106 (6.4%) |
| Functional cyst | 40 (2.4%) |
| Hydrosalpinx + salpingitis | 47 (2.8%) |
| Peritoneal pseudocyst | 18 (1.1%) |
| Abscess | 17 (1.0%) |
| Fibroma | 130 (7.9%) |
| Serous cystadenoma | 259 (15.7%) |
| Mucinous cystadenoma | 183 (11.1%) |
| Rare benign | 48 (2.9%) |
| Primary invasive (epithelial) cancer stage I | 128 (7.7%) |
| Primary invasive (epithelial) cancer stage II | 47 (2.8%) |
| Rare primary invasive malignancy stage I or II * | 55 (3.3%) |
* Includes germ cell tumors and sex cord-stromal tumors.